NEW YORK (Reuters Health) – Active surveillance for renal cortical neoplasm is a “reasonable treatment option” in older patients with comorbid illness, according to a single-center report from…
NEW YORK (Reuters Health) – Sunitinib and sorafenib significantly increase patients’ risk of arterial thromboembolic events, according to a report in the March 29th online issue of the…
NEW YORK (Reuters Health) – Adjuvant chemotherapy, with or without postoperative radiotherapy, improves survival in patients with operable non-small-cell lung cancer, according to a March 24th online report…
NEW YORK (Reuters Health) – Ultrasound surveillance is a safe alternative to immediate resection for small testicular masses discovered incidentally, Canadian researchers report. Small testicular masses are occasionally…
NEW YORK (Reuters Health) – Gene expression-based signatures for lung cancer don’t seem any better than currently used prognostic factors at identifying patients who need adjuvant chemotherapy, researchers…
NEW YORK (Reuters Health) – High-potency, stereotactic body radiation therapy (SBRT) may improve survival for patients with medically inoperable early stage lung cancer, results of a multicenter phase…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – A new biomarker – tumor-associated CD68+ macrophages — predicts poor outcomes in patients with classic Hodgkin’s lymphoma, new research indicates. About 20% of…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – In young women with stage IA1 cervical cancer, a fertility-preserving conization does not reduce survival compared to hysterectomy, researchers report in the March…